Dr. Kibbi is a board-certified dermatologist and fellowship-trained dermatologic surgeon. She is a clinical assistant professor of dermatologic surgery and cutaneous oncology at Stanford University School of Medicine.
Her clinical interests include Mohs micrographic surgery for skin cancer. Dr. Kibbi also specializes in cosmetic dermatology and performs a host of procedures, including laser treatments and injections to combat aging and sun-damaged skin.
Dr. Kibbi has helped thousands of patients with skin cancer. She is committed to educating people about excessive sun exposure and how to reverse and prevent its negative effects. Dr. Kibbi places a premium on patient communication and strives to be thoughtful, honest, and empathetic.
Her research interests include clinical practice guidelines for rare skin tumors, challenging lip lesions, non-invasive treatments, such as photodynamic therapy for non-melanoma skin cancer, and cosmetic dermatologic procedures for medical conditions such as acne scars and autoimmune conditions. Dr. Kibbi has presented at national and international meetings including the American Academy of Dermatology, American Society of Dermatologic Surgery, American College of Mohs Surgery, European Society for Dermatological Research, and others.
Dr. Kibbi has published peer-reviewed articles on topics such as photodynamic therapy for squamous cell carcinoma, clinical management of sebaceous carcinoma, plasma concentration of sunscreen ingredients, and therapeutic strategies for genetic skin disease. Her work has appeared in Lancet Oncology, Journal of the American Academy of Dermatology, British Journal of Dermatology, Journal of Dermatologic Surgery, and elsewhere. She also provides editorial services for the British Journal of Dermatology and is a reviewer for publications including the Journal of the American Academy of Dermatology and Journal of Dermatologic Surgery.
Among her many honors, Dr. Kibbi has earned scholarship and mentorship awards from the American Society of Dermatology Surgery and the Women’s Dermatologic Society. She received the Kenneth Fields fellowship from the American Society of Dermatologic Surgery, a mentorship award from the Women’s Dermatologic Society, and the Harold H. Lamport Biomedical Research Prize from Yale School of Medicine, where she graduated with honors.
Dr. Kibbi was also chief resident of dermatology at Yale New Haven Health. Dr. Kibbi is a member of the American Academy of Dermatology, American College of Mohs Surgery, American Society of Dermatologic Surgery, and the Women’s Dermatologic Society.
Clinical Assistant Professor, Dermatology
Medical Education: Yale School Of Medicine (2015) CT
Fellowship: Yale University Dept of Dermatology (2020) CT
Board Certification: American Board of Dermatology, Dermatology (2019)
Residency: Yale University Dept of Dermatology (2019) CT
Internship: Yale University Internal Medicine Residency (2016) CT
Dermatofibrosarcoma protuberans in pregnancy: a case series and review of the literature
INTERNATIONAL JOURNAL OF DERMATOLOGY
Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous sarcoma, which has been reported in pregnancy. This case series reports the clinical and histopathological findings of DFSP in pregnancy.Eighteen cases of DFSP, including six unreported cases and 12 cases from the literature, were identified. Age, anatomic location, tumor size, changes in tumor characteristics during pregnancy, histopathological features, and treatment were recorded. Follow-up data, when available, were noted.The average age of the cohort was 30.6 years (range 19-38). Ten tumors (55.6%) were located on the trunk, four (22.2%) on the head and neck, three (16.7%) on the extremities,and one (5.6%) in the genitalia. Most tumors demonstrated features of conventional DFSP (12/18, 66.7%), while the remaining were identified as DFSP with fibrosarcomatous (FS) change (3/18, 16.7%), atrophic DFSP (2/18, 11.1%), and myxoid DFSP (1/18, 5.6%). Treatment was reported in 17 cases, at least nine of which were treated postpartum. Ten patients were treated with excision, while seven underwent Mohs micrographic surgery. Three patients recurred on follow-up, one with local recurrence and two with distant metastasis.DFSP can undergo enlargement or change in size or color in pregnancy, possibly mediated by hormones. While the majority of cases in this series represented conventional DFSP, unusual clinical and histopathological variants were also present. Treatment in most cases can be safely delayed until after delivery, but recurrent or very large tumors may require treatment prepartum. Close monitoring for recurrence or metastasis is advised.
View details for DOI 10.1111/ijd.15497
View details for Web of Science ID 000636725000001
View details for PubMedID 33818755
- Reflectance Confocal Microscopy as a Promising Adjunctive Tool for Treatment Planning in Extramammary Paget's Disease. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2020
- Broad versus narrow clinical practice guidelines: avoiding rules for the high risk 1. Archives of dermatological research 2020
- Comparative utility of appropriate use criteria versus clinical practice guidelines. Archives of dermatological research 2020
- Multisociety and multispecialty clinical practice guidelines. Archives of dermatological research 2020
- Development of international clinical practice guidelines: benefits, limitations, and alternative forms of international collaboration. Archives of dermatological research 2020
- Principles for developing and adapting clinical practice guidelines and guidance for pandemics, wars, shortages, and other crises and emergencies: the PAGE criteria. Archives of dermatological research 2020
Predicting outcomes following second intent healing of periocular surgical defects.
Archives of dermatological research
Traditionally, second intent healing (SIH) in the periocular region is reserved for small and/or concave defects, particularly those located on the medial canthus.The purpose of this study was to identify factors impacting outcomes of SIH for periocular tumors following Mohs micrographic surgery (MMS).Retrospective analysis was performed of all periocular lesions treated with MMS followed by SIH from a single academic surgical center over a 5-year period. Data regarding tumor characteristics and follow-up was recorded. The modified Manchester scale was utilized to evaluate scar outcomes.Of the 39 tumors included, 14 (35.9%) were located on the lower eyelid, 12 (30.8%) on the upper eyelid, 6 (15.4%) on the lateral canthus, and 7 (17.9%) on the medial canthus. Involvement of the eyelid margin was seen in 11 (28.2%) of cases. The average defect diameter and area were 1.3 cm and 1.04 cm-squared. Twenty-three cases (59.0%) healed with optimal results. Larger defects were significantly associated with poorer outcomes of SIH (odds ratio 0.205, p = 0.017 by multivariate analysis). Anatomic location, involvement of the lid margin, age, and follow-up interval were not significant factors; however, medial canthus defects were least likely to heal with optimal results. On average, medial canthal lesions were larger in size (mean diameter 1.76 cm, mean area 1.97 cm-squared).This retrospective study suggests that periorbital defects in all locations with area less than 1.04 cm2 heal well by SIH. In this cohort, larger lesions on the medial canthus healed with worse outcomes.
View details for DOI 10.1007/s00403-020-02122-w
View details for PubMedID 32833078